Successful Treatment of a Critically Ill COVID-19 Patient Using Continuous Renal Replacement Therapy With Enhanced Cytokine Removal and Tocilizumab: A Case Report
Thomas Tao-Min Huang(National Taiwan University Hospital), Ashita Tolwani(University of Alabama at Birmingham), Sui‐Yuan Chang(National Taiwan University of Science and Technology), Yu‐Chang Yeh(National Taiwan University Hospital), Shan‐Chwen Chang(National Taiwan University Hospital), Jann‐Tay Wang(National Taiwan University Hospital), Chih‐Hsien Wang(National Taiwan University Hospital), Ying‐Chun Chien(National Taiwan University Hospital), Shih‐Chi Ku(National Taiwan University Hospital), Bor‐Luen Chiang(National Taiwan University), Song-Chou Hsieh(National Taiwan University Hospital), Chong‐Jen Yu(National Taiwan University Hospital)
Cited by 6
Related Papers
Osimertinib in Resected <i>EGFR</i> -Mutated Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2020|1.7k
Clinical activity of afatinib in patients with advanced non-small-cell lung cancer harbouring uncommon EGFR mutations: a combined post-hoc analysis of LUX-Lung 2, LUX-Lung 3, and LUX-Lung 6
|The Lancet Oncology|2015|980
A Novel Virulence Gene in <i>Klebsiella pneumoniae</i> Strains Causing Primary Liver Abscess and Septic Metastatic Complications
|The Journal of Experimental Medicine|2004|779
Identification of Biomarkers for Differentiation of Hypervirulent Klebsiella pneumoniae from Classical K. pneumoniae
|Journal of Clinical Microbiology|2018|775